Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Niacinamide 2%
Product Images NDC 72934-1125

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Niacinamide 2% (NDC 72934-1125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Z (1125 2 End)

Z (1125 2 End)
Text panel showing directions for use of Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Niacinamide 2% topical medication by Sincerus Florida, LLC. Instructions state to apply topically as directed by a physician, wash hands after use, and store at controlled room temperature 20-25°C. Contact information and reporting instructions for suspected adverse reactions are provided.*
FDA Label Image

Z (1125 2 Front)

Z (1125 2 Front)
The image shows a white cylindrical container labeled as IMIQUIMOD USP 5%, LEVOCETIRIZINE DIHYDROCHLORIDE USP 1%, and NIACINAMIDE USP 2% gel in a 30 gm size. The label indicates it is a compounded drug made in the USA by Sincerus Florida, LLC, with NDC 72934-1125-2.*
FDA Label Image

D (1125 2 Middle)

D (1125 2 Middle)
Label on a white container for IMIQUIMOD 5%, LEVOCETIRIZINE DIHYDROCHLORIDE 1%, and NIACINAMIDE 2% topical gel. The label lists active ingredients with their percentages and inactive ingredients including Krisgel 100, Polysorbate 60 NF, and Suspindisse Gel, along with manufacturing and expiry details. Labeler is Sincerus Florida, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.